These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23648086)

  • 61. Pharmacogenomics of alcohol response and addiction.
    Enoch MA
    Am J Pharmacogenomics; 2003; 3(4):217-32. PubMed ID: 12930156
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function.
    Johnson BA
    CNS Drugs; 2005; 19(10):873-96. PubMed ID: 16185095
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Physio-Pharmacological Role of the NPS/NPSR System in Psychiatric Disorders: A Translational Overview.
    Ghazal P
    Curr Protein Pept Sci; 2016; 17(4):380-97. PubMed ID: 26680586
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Combining treatments for alcoholism: why and how?
    Mattson ME; Litten RZ
    J Stud Alcohol Suppl; 2005 Jul; (15):8-16; discussion 6-7. PubMed ID: 16223051
    [TBL] [Abstract][Full Text] [Related]  

  • 65. What Is Addiction? How Can Animal and Human Research Be Used to Advance Research, Diagnosis, and Treatment of Alcohol and Other Substance Use Disorders?
    Bickel WK; Crabbe JC; Sher KJ
    Alcohol Clin Exp Res; 2019 Jan; 43(1):6-21. PubMed ID: 30371956
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neuropeptide modulation of addiction: Focus on galanin.
    Genders SG; Scheller KJ; Djouma E
    Neurosci Biobehav Rev; 2020 Mar; 110():133-149. PubMed ID: 29949733
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Exploring the Neurochemical Basis of Alcohol Addiction-Related Behaviors: Translational Research.
    Budygin EA; Weiner JL
    Transl Biomed; 2015; 6(Suppl Spec):. PubMed ID: 26770883
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence.
    Mason BJ; Heyser CJ
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):23-32. PubMed ID: 20201812
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues.
    Heilig M; Thorsell A; Sommer WH; Hansson AC; Ramchandani VA; George DT; Hommer D; Barr CS
    Neurosci Biobehav Rev; 2010 Nov; 35(2):334-44. PubMed ID: 19941895
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role of neuropeptides in drug and ethanol abuse: Medication targets for drug and alcohol use disorders.
    Barson JR
    Brain Res; 2020 Aug; 1740():146876. PubMed ID: 32387136
    [No Abstract]   [Full Text] [Related]  

  • 71. From Homer and Hippocrates to modern personalized medicine: is there a role for pharmacoepigenomics in the treatment of alcohol addiction?
    Ragia G; Manolopoulos VG
    Pharmacogenomics; 2018 Apr; 19(6):513-516. PubMed ID: 29580163
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Stress, alcohol and drug interaction: an update of human research.
    Uhart M; Wand GS
    Addict Biol; 2009 Jan; 14(1):43-64. PubMed ID: 18855803
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Personality driven alcohol and drug abuse: New mechanisms revealed.
    Skóra MN; Pattij T; Beroun A; Kogias G; Mielenz D; de Vries T; Radwanska K; Müller CP
    Neurosci Biobehav Rev; 2020 Sep; 116():64-73. PubMed ID: 32565173
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Epigenetics-beyond the genome in alcoholism.
    Starkman BG; Sakharkar AJ; Pandey SC
    Alcohol Res; 2012; 34(3):293-305. PubMed ID: 23134045
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Probing for Neuroadaptations to Unpredictable Stressors in Addiction: Translational Methods and Emerging Evidence.
    Kaye JT; Bradford DE; Magruder KP; Curtin JJ
    J Stud Alcohol Drugs; 2017 May; 78(3):353-371. PubMed ID: 28499100
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reduced limbic metabolism and fronto-cortical volume in rats vulnerable to alcohol addiction.
    Gozzi A; Agosta F; Massi M; Ciccocioppo R; Bifone A
    Neuroimage; 2013 Apr; 69():112-9. PubMed ID: 23261637
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Subjective Response to Alcohol as a Research Domain Criterion.
    Ray LA; Bujarski S; Roche DJ
    Alcohol Clin Exp Res; 2016 Jan; 40(1):6-17. PubMed ID: 26727518
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Pharmacological modulation of nitrogen oxide system in experimental chronic alcoholic intoxication in rats].
    Belenichev IF; Sokolik EP
    Eksp Klin Farmakol; 2011; 74(10):43-5. PubMed ID: 22238987
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Different Molecular/Behavioral Endophenotypes in C57BL/6J Mice Predict the Impact of OX
    Alcaraz-Iborra M; Navarrete F; Rodríguez-Ortega E; de la Fuente L; Manzanares J; Cubero I
    Front Behav Neurosci; 2017; 11():186. PubMed ID: 29066961
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Neurokinin 1 receptor blockade in the medial amygdala attenuates alcohol drinking in rats with innate anxiety but not in Wistar rats.
    Ayanwuyi LO; Stopponi S; Ubaldi M; Cippitelli A; Nasuti C; Damadzic R; Heilig M; Schank J; Cheng K; Rice KC; Ciccocioppo R
    Br J Pharmacol; 2015 Nov; 172(21):5136-46. PubMed ID: 26275374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.